Clinical characteristics and outcomes of pediatric methylphenidate intoxication: a five-year single-center study
Open Access
- 26 June 2026
- journal article
- Published by Springer Nature in BMC Pharmacology and Toxicology
- Vol. 27 (1)
Abstract
Methylphenidate is widely prescribed for attention-deficit/hyperactivity disorder, and its use has increased substantially in recent years. Although generally considered safe within therapeutic ranges, supratherapeutic ingestion may result in various systemic adverse effects. This study aimed to evaluate the demographic and clinical characteristics of children presenting with overdose ingestion and to identify potential factors associated with symptom development. We conducted a retrospective review of patients younger than 18 years who presented to a tertiary pediatric emergency department between January 1, 2020, and December 31, 2024, due to overdose ingestion. Demographic characteristics, psychiatric history, ingested dose, mode of exposure, clinical findings, emergency department course, and factors potentially associated with adverse effects were analyzed. Thirty-two patients were included; 72% were female, and ingestion was intentional in 84%. The mean ingested dose was 5.7 mg/kg. Clinical symptoms developed in 41% of patients. The most frequent findings were tachycardia (38%), mild hypertension (34%), agitation (22%), and seizures (16%). Although most cases were mild and resolved within 12 h of observation, one toddler developed neuropsychiatric manifestations requiring close monitoring with full recovery within 48 h. No statistically significant association was observed between age, sex, gastrointestinal decontamination status, or reported ingested dose and the development of clinical symptoms (p > 0.05). Pediatric methylphenidate intoxication is generally mild, but severe neuropsychiatric and cardiovascular effects may occur. Careful clinical monitoring remains essential. Not applicable.Keywords
This publication has 20 references indexed in Scilit:
- Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and ManagementCNS Drugs, 2013
- Dexmedetomidine in a Child with Methylphenidate IntoxicationIndian Journal of Pediatrics, 2012
- Case report: intoxication with high dose of long-acting methylphenidate (Concerta®) in a suicidal 14-year-old girlADHD Attention Deficit and Hyperactivity Disorders, 2010
- A case of suicide attempt with long-acting methylphenidate (Concerta)ADHD Attention Deficit and Hyperactivity Disorders, 2010
- Methylphenidate poisoning: An evidence-based consensus guideline for out-of-hospital managementClinical Toxicology, 2007
- Methylphenidate Abuse in Texas, 1998–2004Journal of Toxicology and Environmental Health, Part A, 2006
- Methylphenidate Unintentional Ingestion in Preschool ChildrenTherapeutic Drug Monitoring, 2005
- Poison Centers’ Experience With Methylphenidate Abuse in Pre-Teens and AdolescentsJournal of the American Academy of Child & Adolescent Psychiatry, 2003
- Abuse and toxicity of methylphenidateCurrent Opinion in Pediatrics, 2002
- Characterization of Methylphenidate Exposures Reported to a Regional Poison Control CenterArchives of Pediatrics & Adolescent Medicine, 2000